Spain is at the forefront of Neuroblastoma treatment, with renowned institutions like Centro Médico Teknon, SJD Barcelona Children’s Hospital, and HM Hospitales offering cutting-edge therapies. Centro Médico Teknon, accredited by Joint Commission International, provides advanced diagnostic and treatment services. SJD Barcelona Children’s Hospital is recognized as a leading center for pediatric oncology in Europe, with a dedicated Laboratory for Molecular Medicine focusing on innovative treatment methods. HM Hospitales, a network of seven medical centers, includes four comprehensive centers specializing in oncology treatment.
Innovative procedures such as immunotherapy, transplantation, targeted therapy, and minimally invasive surgery are among the latest advancements in Neuroblastoma treatment in Spain. The survival rate for Neuroblastoma in Spain reaches 70%, with success rates in early-stage treatment exceeding 80% due to precise diagnostics and personalized treatment approaches. These institutions not only offer world-class medical care but also contribute to the development of new therapies, ensuring high-quality patient outcomes.